• No results found

Basic and clinical aspects of mucosal inflammation and healing in Crohn's disease

N/A
N/A
Protected

Academic year: 2021

Share "Basic and clinical aspects of mucosal inflammation and healing in Crohn's disease"

Copied!
9
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Citation

Gao, Q. (2005, February 1). Basic and clinical aspects of mucosal inflammation and healing

in Crohn's disease. Retrieved from https://hdl.handle.net/1887/850

Version: Corrected Publisher’s Version

License: Licence agreement concerning inclusion of doctoral thesis in theInstitutional Repository of the University of Leiden Downloaded from: https://hdl.handle.net/1887/850

(2)

Basic and Clinical Aspects of M ucosal Inflammation

and Healing in Crohn'

s Disease

(3)

electronic or mechanical, without prior written permission of the publisher.

(4)

Basic and Clinical Aspects of Mucosal Inflammation

and Healing in Crohn's Disease

Proefschrift

ter verkrijging van

de graad van Doctor aan de Universiteit Leiden, op gezag van de Rector Magnificus Dr. D.D. Breimer,

hoogleraar in de faculteit der Wiskunde en Natuurwetenschappen en die der Geneeskunde, volgens besluit van het College voor Promoties

te verdedigen op dinsdag 1 februari 2005 klokke 14.15 uur

door

Qiang Gao

(5)

Referent: Prof. dr. T.W.J. Huizinga

Overige leden: Dr. M.N. Aparicio Pagés, Rijnstate Ziekenhuis Arnhem Prof. dr. P.S. Hiemstra

Dr. R.A. van Hogezand

Prof. dr. J.B.M.J. Jansen, Radboud Universiteit Nijmegen Prof. dr. A.S. Peña, Vrije Universiteit Amsterdam

(6)
(7)
(8)

Contents

Chapter 1

Introduction

Chapter 2

M ucosal expression of bFGF, FGFR-1 and Syndecan-1 and their mRNA in Inflammatory Bowel Disease (IBD)

Chapter 3

basic Fibroblast Growth Factor (bFGF) as a response parameter to infliximab in fistulizing Crohn's disease

Chapter 4

Influence of infliximab on the expression of basic Fibroblast Growth Factor (bFGF) in patients with Crohn's disease

Chapter 5

TNF-D assessment during infliximab treatment for Crohn's disease: interference and cellular mechanisms

Chapter 6

Expression of matrix metalloproteinases (M M P)-2 and M M P-9 in intestinal tissue of patients with inflammatory bowel diseases (IBD)

Chapter 7

Infliximab influences the expression of matrix metalloproteinase (M M P)-2 and -9 in Crohn's disease

Chapter 8

General Discussion and Summary

Samenvatti

ng

Ё᭛ᨬ㽕

Acknowl

edgements

Curri

cul

um Vi

tae

Appendi

x

Colour plates of the immunohistochemical pictures

(9)

Referenties

GERELATEERDE DOCUMENTEN

The work described in this thesis was performed at the department of Clinical Epidemiology at the Leiden University Medical Center in Leiden, the Netherlands and at the department

Control group: Blood samples without LPS stimulation were incubated with 0.9% NaCl, at an equal volume to LPS and/or infliximab solutions under the same

This preliminary study revealed that the healing of fistulas in CD by treatment with infliximab is accompanied by a decrease in serum bFGF levels, whereas the

ÍΟÏ0ÐÑÒÓÒÔ Ð ÕÖ®×AؼÙÐ Ú]Ú!ÖÚ]Ð ÖpÛÛÖ®Ü0ØÝÞ]ÕÒßUßÒÔ ÖàØÑÔ áâÕÐ Öã Öä0ÙØ ÙÖpâUÒßßÒdä–Ü0å æ ÕçÐ èÐ éGÒÓêÖëBÕâÞ!ìpáã ÒÔ Þ!íÓÒíÐ ÚmîÓâÖÓã ÒíÔOìâÖëBÔ ï ð

[28] did not find epithelial cell or extracellular matrix staining in normal colonic mucosa, but found that immunoreactivity for bFGF was particularly present at the

In the mucosal inflammation of the intestine, the intestinal epithelial cell not only processes the antigens but also actively participates, together with other non-immune

License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden Downloaded from: https://hdl.handle.net/1887/850..

The work described in this thesis was performed at the department of clinical epidemiology, Leiden University Medical Center, Leiden, the Netherlands, and the Cardiovascular